Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes (PREDICTIVE™)

Novo Nordisk

Status: Completed

Conditions: Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin detemir

Study type: Observational

Funder types: Industry

Identifiers

NCT00704574

NN304-1920

Details and patient eligibility

About

This observational study is conducted in Europe. The trial aims to observe the incidence of serious adverse drug reactions in children and adolescents with type 1 diabetes during Levemir® treatment.

Enrollment: 159 patients

Sex: All

Ages: 6 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Informed consent obtained prior to any trial-related activities
• Any patient with diabetes type 1 is eligible for the study, including newly
• The selection of the patients will be at the discretion of the individual physician

Exclusion criteria

• Type 2 diabetes
• Currently treated with Levemir®

Trial design

159 participants in 1 patient group

A

Treatment:

Drug: insulin detemir